{"transactions":[{"id":1485250,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:49:06.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest on the earlier of the twelve-month anniversary of June 6, 2024 or the day before the next annual stockholder meeting, subject to the Reporting Person continuing to be a Service Provider through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":193066,"source":{"system":"sec-edgar","filing":"0001415889-24-016309","document":"form4-06112024_120602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000141588924016309/form4-06112024_120602.xml","form_type":"4"}},{"id":1503950,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-05-23T19:11:13.000Z","date":"2024-05-21","kind":"other","planned":false,"acquired":false,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.5,"exercise_date":"2022-03-31","expiration_date":"2027-03-31","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001415889-24-014389","document":"form4-05232024_110501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000141588924014389/form4-05232024_110501.xml","form_type":"4"}},{"id":1503949,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T19:11:13.000Z","date":"2024-05-21","kind":"other","planned":false,"acquired":true,"shares":62000,"price":4.5,"value":279000.0,"ownership":{"direct":true},"balance_after":186566,"source":{"system":"sec-edgar","filing":"0001415889-24-014389","document":"form4-05232024_110501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000141588924014389/form4-05232024_110501.xml","form_type":"4"}},{"id":1681774,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-10T16:31:08.000Z","date":"2024-01-08","kind":"gift","planned":false,"acquired":false,"shares":3523,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":124566,"source":{"system":"sec-edgar","filing":"0001209191-24-001353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000120919124001353/doc4.xml","form_type":"4"}},{"id":1724119,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-04T20:41:26.000Z","date":"2023-11-30","kind":"gift","planned":false,"acquired":false,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of shares held directly no longer includes 20,752 shares which are now reported below as held by Mildred Mario Nonexempt Trust, of which the Reporting Person is a co-trustee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned has been reduced by one share pursuant to an internal review of the Reporting Person's holdings."}],"balance_after":128089,"source":{"system":"sec-edgar","filing":"0001209191-23-057329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000120919123057329/doc4.xml","form_type":"4"}},{"id":1876842,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-26T18:29:37.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option shall vest on November 26, 2023, subject to the Reporting Person continuing to be a Service Provider through such date."}],"balance_after":10000,"derivative":{"exercise_price":5.25,"expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-032695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000120919123032695/doc4.xml","form_type":"4"}},{"id":1876841,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-26T18:29:37.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":2666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option shall vest on the earlier of the twelve-month anniversary of May 25, 2023 or the day before the next annual stockholder meeting, subject to the Reporting Person continuing to be a Service Provider through such date."}],"balance_after":2666,"derivative":{"exercise_price":5.03,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":2666},"source":{"system":"sec-edgar","filing":"0001209191-23-032695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000120919123032695/doc4.xml","form_type":"4"}},{"id":2137176,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-10-14T18:29:49.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":2666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option shall vest on the earlier of the twelve-month anniversary of June 1, 2022 or the day before the next annual stockholder meeting, subject to Reporting Person continuing to be a Service Provider through each such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022."}],"balance_after":2666,"derivative":{"exercise_price":2.55,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":2666},"source":{"system":"sec-edgar","filing":"0001209191-22-053696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000120919122053696/doc4.xml","form_type":"4"}},{"id":2308815,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2022-04-04T16:07:45.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":930000,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with one (1) warrant to purchase one (1) share of common stock for an aggregate price of $0.25."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Mario 1998 Irrevocable Trust, of which Dr. Mario is the ultimate beneficiary."}],"balance_after":930000,"derivative":{"exercise_price":0.3,"exercise_date":"2022-03-31","expiration_date":"2027-03-31","underlying":"Common Stock","underlying_shares":930000},"source":{"system":"sec-edgar","filing":"0000899243-22-013315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924322013315/doc4.xml","form_type":"4"}},{"id":2308814,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2022-04-04T16:07:45.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":930000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with one (1) warrant to purchase one (1) share of common stock for an aggregate price of $0.25."}],"balance_after":930000,"derivative":{"exercise_price":0.3,"exercise_date":"2022-03-31","expiration_date":"2027-03-31","underlying":"Common Stock","underlying_shares":930000},"source":{"system":"sec-edgar","filing":"0000899243-22-013315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924322013315/doc4.xml","form_type":"4"}},{"id":2308813,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T16:07:45.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":930000,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with one (1) warrant to purchase one (1) share of common stock for an aggregate price of $0.25."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Mario 1998 Irrevocable Trust, of which Dr. Mario is the ultimate beneficiary."}],"balance_after":930000,"source":{"system":"sec-edgar","filing":"0000899243-22-013315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924322013315/doc4.xml","form_type":"4"}},{"id":2308812,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T16:07:45.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":930000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with one (1) warrant to purchase one (1) share of common stock for an aggregate price of $0.25."}],"balance_after":2363135,"source":{"system":"sec-edgar","filing":"0000899243-22-013315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924322013315/doc4.xml","form_type":"4"}},{"id":2417087,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-02T20:52:53.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":56338,"price":0.355,"value":19999.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\").  Each RSU represents a contingent right to receive one share of SLNO common stock.  The RSUs are fully vested on January 31, 2022."}],"balance_after":1433135,"source":{"system":"sec-edgar","filing":"0000899243-22-004260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924322004260/doc4.xml","form_type":"4"}},{"id":2501169,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-22T09:11:37.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":9653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control."}],"balance_after":9653,"derivative":{"exercise_price":3.59,"expiration_date":"2031-11-17","underlying":"Common Stock","underlying_shares":9653},"source":{"system":"sec-edgar","filing":"0001415889-21-005359","document":"form4-11222021_061130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000141588921005359/form4-11222021_061130.xml","form_type":"4"}},{"id":2501168,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001","published_at":"2021-11-22T09:11:37.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":6963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that fully vest on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control."}],"balance_after":382706,"source":{"system":"sec-edgar","filing":"0001415889-21-005359","document":"form4-11222021_061130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000141588921005359/form4-11222021_061130.xml","form_type":"4"}},{"id":2529338,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T16:49:08.000Z","date":"2021-10-29","kind":"grant","acquired":true,"shares":26888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\").  Each RSU represents a contingent right to receive one share of SLNO common stock.  The RSUs are fully vested on October 29, 2021."}],"balance_after":1376797,"source":{"system":"sec-edgar","filing":"0000899243-21-042387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924321042387/doc4.xml","form_type":"4"}},{"id":2618195,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T16:05:49.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":21978,"price":0.91,"value":19999.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\").  Each RSU represents a contingent right to receive one share of SLNO common stock.  The RSUs are fully vested on July 30, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned has been adjusted pursuant to an internal review of the Reporting Person's holdings."}],"balance_after":1349909,"source":{"system":"sec-edgar","filing":"0000899243-21-031259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924321031259/doc4.xml","form_type":"4"}},{"id":2681288,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2021-06-04T16:26:09.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":31862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option shall vest on the earlier of the twelve-month anniversary of June 1, 2022 or the day before the next annual stockholder meeting, subject to Reporting Person continuing to be a Service Provider through each such date."}],"balance_after":31862,"derivative":{"exercise_price":1.02,"expiration_date":"2021-06-01","underlying":"Common Stock","underlying_shares":31862},"source":{"system":"sec-edgar","filing":"0000899243-21-022031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924321022031/doc4.xml","form_type":"4"}},{"id":2730541,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T18:44:08.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":16529,"price":1.21,"value":20000.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\").  Each RSU represents a contingent right to receive one share of SLNO common stock.  The RSUs are fully vested on April 30, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned has been adjusted pursuant to an internal review of the Reporting Person's holdings."}],"balance_after":1176416,"source":{"system":"sec-edgar","filing":"0000899243-21-018235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924321018235/doc4.xml","form_type":"4"}},{"id":2886198,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-02T18:52:36.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":8928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\").  Each RSU represents a contingent right to receive one share of SLNO common stock.  The RSUs fully vested on January 29, 2021."}],"balance_after":1157804,"source":{"system":"sec-edgar","filing":"0000899243-21-004269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924321004269/doc4.xml","form_type":"4"}},{"id":2899477,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T17:05:49.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in four equal quarterly installments from the option grant date."}],"balance_after":49000,"derivative":{"exercise_price":4.44,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001250853-21-000018","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000125085321000018/primary_doc.xml","form_type":"4"}},{"id":2904662,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Warrant","published_at":"2021-01-19T16:40:37.000Z","date":"2021-01-15","kind":"other","acquired":false,"shares":41216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price per share of the Issuer's common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of shares of Issuer common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares of Issuer common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events."}],"balance_after":0,"derivative":{"exercise_price":2.27,"exercise_date":"2020-03-24","expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":41216},"source":{"system":"sec-edgar","filing":"0001638599-21-000068","document":"doc4_7003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859921000068/doc4_7003.xml","form_type":"4"}},{"id":2904661,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001","published_at":"2021-01-19T16:40:37.000Z","date":"2021-01-15","kind":"other","acquired":true,"shares":41216,"price":2.27,"value":93560.32,"ownership":{"direct":true},"balance_after":375743,"source":{"system":"sec-edgar","filing":"0001638599-21-000068","document":"doc4_7003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859921000068/doc4_7003.xml","form_type":"4"}},{"id":2909769,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2021-01-12T21:23:06.000Z","date":"2021-01-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the Option shall be deemed vested on the Transaction Date (which is January 8, 2021)."}],"balance_after":40000,"derivative":{"exercise_price":2.24,"expiration_date":"2031-01-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-21-001714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924321001714/doc4.xml","form_type":"4"}},{"id":2995050,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-03T19:10:58.000Z","date":"2020-10-30","kind":"grant","acquired":true,"shares":10057,"price":1.74,"value":17499.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\").  Each RSU represents a contingent right to receive one share of SLNO common stock.  The RSUs fully vest on October 30, 2020."}],"balance_after":1148876,"source":{"system":"sec-edgar","filing":"0000899243-20-030309","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924320030309/doc4.xml","form_type":"4"}},{"id":3031545,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-15T16:18:02.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":9820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable on the earlier of September 11, 2021 or the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control."}],"balance_after":9820,"derivative":{"exercise_price":3.43,"expiration_date":"2030-09-11","underlying":"Common Stock","underlying_shares":9820},"source":{"system":"sec-edgar","filing":"0001104659-20-105238","document":"tm2030853d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000110465920105238/tm2030853d6_4.xml","form_type":"4"}},{"id":3031544,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001","published_at":"2020-09-15T16:18:02.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":7288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on the earlier of September 11, 2021 or the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control."}],"balance_after":334527,"source":{"system":"sec-edgar","filing":"0001104659-20-105238","document":"tm2030853d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000110465920105238/tm2030853d6_4.xml","form_type":"4"}},{"id":3071499,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-03T17:41:07.000Z","date":"2020-07-31","kind":"grant","acquired":true,"shares":10174,"price":1.72,"value":17499.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\").  Each RSU represents a contingent right to receive one share of SLNO common stock.  The RSUs fully vest on July 31, 2020."}],"balance_after":10174,"source":{"system":"sec-edgar","filing":"0000899243-20-021015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924320021015/doc4.xml","form_type":"4"}},{"id":3141044,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2020-05-20T18:04:48.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":9530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the Option shall vest on the one year anniversary of the Transaction Date (which is May 18, 2020) or the day before the 2020 Annual Shareholder Meeting, whichever is earlier."}],"balance_after":9530,"derivative":{"exercise_price":3.41,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":9530},"source":{"system":"sec-edgar","filing":"0000899243-20-013727","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924320013727/doc4.xml","form_type":"4"}},{"id":3163832,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-04T21:43:38.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":5738,"price":3.05,"value":17500.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\").  Each RSU represents a contingent right to receive one share of SLNO common stock.  The RSUs fully vest on April 30, 2020."}],"balance_after":5738,"source":{"system":"sec-edgar","filing":"0000899243-20-011971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924320011971/doc4.xml","form_type":"4"}},{"id":3194508,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Warrant","published_at":"2020-03-26T18:12:03.000Z","date":"2020-03-24","kind":"purchase","acquired":true,"shares":61823,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price per share of the Issuer's common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events."},{"field":"shares","element":"transactionShares","label":"F4","text":"The number of shares of Issuer common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 24, 2020, the Reporting Person purchased Units from the Issuer in a private placement, with each Unit consisting of (a) one share of the Issuer's common stock, (b) a Class A Warrant representing the right to acquire 0.5 shares of the Issuer's common stock and (c) a Class B Warrant representing the right to acquire 0.75 shares of the Issuer's common stock. The purchase price for each Unit was $2.42625 of which $2.27 was for the share of the Issuer's common stock, $0.06250 was for the Class A Warrant and $0.09375 was for the Class B Warrant."}],"balance_after":61823,"derivative":{"exercise_price":2.724,"exercise_date":"2020-03-24","expiration_date":"2025-03-24","underlying":"Common Stock","underlying_shares":61823},"source":{"system":"sec-edgar","filing":"0001638599-20-000345","document":"doc4_6614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859920000345/doc4_6614.xml","form_type":"4"}},{"id":3194507,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Warrant","published_at":"2020-03-26T18:12:03.000Z","date":"2020-03-24","kind":"purchase","acquired":true,"shares":41216,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price per share of the Issuer's common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events."},{"field":"shares","element":"transactionShares","label":"F4","text":"The number of shares of Issuer common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 24, 2020, the Reporting Person purchased Units from the Issuer in a private placement, with each Unit consisting of (a) one share of the Issuer's common stock, (b) a Class A Warrant representing the right to acquire 0.5 shares of the Issuer's common stock and (c) a Class B Warrant representing the right to acquire 0.75 shares of the Issuer's common stock. The purchase price for each Unit was $2.42625 of which $2.27 was for the share of the Issuer's common stock, $0.06250 was for the Class A Warrant and $0.09375 was for the Class B Warrant."}],"balance_after":41216,"derivative":{"exercise_price":2.27,"exercise_date":"2020-03-24","expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":41216},"source":{"system":"sec-edgar","filing":"0001638599-20-000345","document":"doc4_6614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859920000345/doc4_6614.xml","form_type":"4"}},{"id":3194506,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001","published_at":"2020-03-26T18:12:03.000Z","date":"2020-03-24","kind":"purchase","acquired":true,"shares":82431,"price":2.27,"value":187118.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 24, 2020, the Reporting Person purchased Units from the Issuer in a private placement, with each Unit consisting of (a) one share of the Issuer's common stock, (b) a Class A Warrant representing the right to acquire 0.5 shares of the Issuer's common stock and (c) a Class B Warrant representing the right to acquire 0.75 shares of the Issuer's common stock. The purchase price for each Unit was $2.42625 of which $2.27 was for the share of the Issuer's common stock, $0.06250 was for the Class A Warrant and $0.09375 was for the Class B Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of shares beneficially owned by the Reporting Person has been adjusted to reflect shares of the Issuer's common stock that are no longer beneficially attributed to the Reporting Person since he resigned as trustee of the Mario 2002 Children's Trust."}],"balance_after":327239,"source":{"system":"sec-edgar","filing":"0001638599-20-000345","document":"doc4_6614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859920000345/doc4_6614.xml","form_type":"4"}},{"id":3303136,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T16:08:31.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":10448,"price":3.35,"value":35000.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\").  Each RSU represents a contingent right to receive one share of SLNO common stock.  The RSUs fully vest on January 22, 2020."}],"balance_after":10448,"source":{"system":"sec-edgar","filing":"0000899243-20-001963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924320001963/doc4.xml","form_type":"4"}},{"id":3305427,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-22T18:41:33.000Z","date":"2020-01-17","kind":"grant","acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in four equal quarterly installments from the option grant date."}],"balance_after":49000,"derivative":{"exercise_price":9.84,"expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001250853-20-000026","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000125085320000026/primary_doc.xml","form_type":"4"}},{"id":3362009,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:41.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":4756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4756},"source":{"system":"sec-edgar","filing":"0001415889-19-001367","document":"form4-11222019_071129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001367/form4-11222019_071129.xml","form_type":"4"}},{"id":3362008,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:41.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001415889-19-001367","document":"form4-11222019_071129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001367/form4-11222019_071129.xml","form_type":"4"}},{"id":3362007,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:41.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001415889-19-001367","document":"form4-11222019_071129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001367/form4-11222019_071129.xml","form_type":"4"}},{"id":3362006,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:41.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":13266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":77.38,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":13266},"source":{"system":"sec-edgar","filing":"0001415889-19-001367","document":"form4-11222019_071129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001367/form4-11222019_071129.xml","form_type":"4"}},{"id":3362005,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:41.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":121.04,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001415889-19-001367","document":"form4-11222019_071129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001367/form4-11222019_071129.xml","form_type":"4"}},{"id":3362004,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:41.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":99.98,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001415889-19-001367","document":"form4-11222019_071129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001367/form4-11222019_071129.xml","form_type":"4"}},{"id":3362003,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:41.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":112.16,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-19-001367","document":"form4-11222019_071129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001367/form4-11222019_071129.xml","form_type":"4"}},{"id":3362002,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:41.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":20700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":88.5,"expiration_date":"2024-07-01","underlying":"Common Stock","underlying_shares":20700},"source":{"system":"sec-edgar","filing":"0001415889-19-001367","document":"form4-11222019_071129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001367/form4-11222019_071129.xml","form_type":"4"}},{"id":3362001,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T07:30:41.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":4908,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 2, 2019, by and among Celgene Corporation (\"Celgene\"), Bristol-Myers Squibb Company (\"BMS\"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the \"Effective Time\"), each share of Celgene common stock was converted into the right to receive (i) $50.00 in cash, (ii) one share of BMS common stock, and (iii) one contingent value right (\"CVR\") issued by BMS subject to and in accordance with the CVR agreement, dated November 20, 2019, by and between BMS and the Equiniti Trust Company."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-19-001367","document":"form4-11222019_071129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001367/form4-11222019_071129.xml","form_type":"4"}},{"id":3362000,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T07:30:41.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":62884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 2, 2019, by and among Celgene Corporation (\"Celgene\"), Bristol-Myers Squibb Company (\"BMS\"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the \"Effective Time\"), each share of Celgene common stock was converted into the right to receive (i) $50.00 in cash, (ii) one share of BMS common stock, and (iii) one contingent value right (\"CVR\") issued by BMS subject to and in accordance with the CVR agreement, dated November 20, 2019, by and between BMS and the Equiniti Trust Company."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-19-001367","document":"form4-11222019_071129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001367/form4-11222019_071129.xml","form_type":"4"}},{"id":3433361,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-20T17:21:18.000Z","date":"2019-08-16","kind":"grant","acquired":true,"shares":9057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control."}],"balance_after":9057,"derivative":{"exercise_price":3.11,"expiration_date":"2029-08-16","underlying":"Common Stock","underlying_shares":9057},"source":{"system":"sec-edgar","filing":"0001638599-19-000794","document":"doc4_6256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859919000794/doc4_6256.xml","form_type":"4"}},{"id":3433360,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001","published_at":"2019-08-20T17:21:18.000Z","date":"2019-08-16","kind":"grant","acquired":true,"shares":8038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control."}],"balance_after":280779,"source":{"system":"sec-edgar","filing":"0001638599-19-000794","document":"doc4_6256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859919000794/doc4_6256.xml","form_type":"4"}},{"id":3462041,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001","published_at":"2019-07-15T17:46:51.000Z","date":"2019-07-11","kind":"purchase","acquired":true,"shares":35971,"price":2.78,"value":99999.38,"ownership":{"direct":true},"balance_after":272741,"source":{"system":"sec-edgar","filing":"0001638599-19-000655","document":"doc4_6179.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859919000655/doc4_6179.xml","form_type":"4"}},{"id":3488747,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-17T16:00:37.000Z","date":"2019-06-15","kind":"exercise","acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001415889-19-000730","document":"form4-06172019_040624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000730/form4-06172019_040624.xml","form_type":"4"}},{"id":3488746,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-17T16:00:37.000Z","date":"2019-06-14","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The remainder of the restricted stock units will vest as follows: 300 shares on June 14, 2020. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."}],"balance_after":300,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001415889-19-000730","document":"form4-06172019_040624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000730/form4-06172019_040624.xml","form_type":"4"}},{"id":3488745,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-17T16:00:37.000Z","date":"2019-06-13","kind":"exercise","acquired":false,"shares":484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The remainder of the restricted stock units will vest in two annual installments as follows: 485 shares on June 13, 2020 and 485 shares on June 13, 2021. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."}],"balance_after":970,"derivative":{"underlying":"Common Stock","underlying_shares":484},"source":{"system":"sec-edgar","filing":"0001415889-19-000730","document":"form4-06172019_040624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000730/form4-06172019_040624.xml","form_type":"4"}},{"id":3488744,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T16:00:37.000Z","date":"2019-06-15","kind":"exercise","acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":62884,"source":{"system":"sec-edgar","filing":"0001415889-19-000730","document":"form4-06172019_040624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000730/form4-06172019_040624.xml","form_type":"4"}},{"id":3488743,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T16:00:37.000Z","date":"2019-06-14","kind":"exercise","acquired":true,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."}],"balance_after":62509,"source":{"system":"sec-edgar","filing":"0001415889-19-000730","document":"form4-06172019_040624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000730/form4-06172019_040624.xml","form_type":"4"}},{"id":3488742,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T16:00:37.000Z","date":"2019-06-13","kind":"exercise","acquired":true,"shares":484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of shares beneficially owned following the reported transaction also includes (i) 324 shares previously reported as held by spouse and indirectly owned, (ii) an aggregate of 5,676 shares that were acquired prior to the reporting person becoming a director of the Company in August 2007 and were inadvertently omitted from the reporting person's initial Form 3 filing and (iii) an aggregate of 720 shares that were acquired in December 2007 and were never reported on a Form 4 filing."}],"balance_after":62209,"source":{"system":"sec-edgar","filing":"0001415889-19-000730","document":"form4-06172019_040624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000730/form4-06172019_040624.xml","form_type":"4"}},{"id":3492930,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2019-06-12T17:36:31.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the Option shall vest on the one year anniversary of the Transaction Date (which is June 10, 2019) or the day before the 2019 Annual Shareholder Meeting, whichever is earlier."}],"balance_after":13000,"derivative":{"exercise_price":2.5,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000899243-19-016667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924319016667/doc4.xml","form_type":"4"}},{"id":3501337,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-05T16:05:28.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":4756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in three annual installments as follows: 1,585 shares on June 3, 2020; 1,585 shares on June 3, 2021; and 1,586 shares on June 3, 2022.  Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest in three annual installments as follows: 1,585 shares on June 3, 2020; 1,585 shares on June 3, 2021; and 1,586 shares on June 3, 2022.  Vested shares will be delivered to the reporting person promptly after the vesting date."}],"balance_after":4756,"derivative":{"underlying":"Common Stock","underlying_shares":4756},"source":{"system":"sec-edgar","filing":"0001415889-19-000663","document":"form4-06052019_040615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000663/form4-06052019_040615.xml","form_type":"4"}},{"id":3517012,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001","published_at":"2019-05-21T17:24:24.000Z","date":"2018-01-29","kind":"purchase","acquired":true,"shares":90000,"price":10,"value":900000.0,"ownership":{"direct":true},"balance_after":236770,"source":{"system":"sec-edgar","filing":"0001638599-19-000539","document":"doc4_6117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859919000539/doc4_6117.xml","form_type":"4"}},{"id":3607089,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-07T16:05:16.000Z","date":"2019-03-05","kind":"other","acquired":true,"shares":2908,"price":85.97,"value":250000.76,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the transfer of shares pursuant to an exemption under Rule 16a-13 to the Ernest Mario 15-year Residence Trust (the \"GRAT\"), for which the reporting person is the trustee, in exchange for cash pursuant to the terms of the GRAT."}],"balance_after":4908,"source":{"system":"sec-edgar","filing":"0001415889-19-000284","document":"form4-03072019_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000284/form4-03072019_040301.xml","form_type":"4"}},{"id":3607088,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-07T16:05:16.000Z","date":"2019-03-05","kind":"other","acquired":false,"shares":2908,"price":85.97,"value":250000.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the transfer of shares pursuant to an exemption under Rule 16a-13 to the Ernest Mario 15-year Residence Trust (the \"GRAT\"), for which the reporting person is the trustee, in exchange for cash pursuant to the terms of the GRAT."}],"balance_after":55005,"source":{"system":"sec-edgar","filing":"0001415889-19-000284","document":"form4-03072019_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000284/form4-03072019_040301.xml","form_type":"4"}},{"id":3658638,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-14T16:05:14.000Z","date":"2019-02-12","kind":"purchase","acquired":true,"shares":2000,"price":89.99,"value":179980.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased by the reporting person in multiple transactions at prices ranging from $89.985 to $90.00, inclusive. The reporting person undertakes to provide Celgene Corporation (the \"Company\"), any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities  and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purpose of Section 16 or for any other purpose.  These shares are held in the Ernest Mario 15-Year Residence Trustee, for which the reporting person is the trustee."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-19-000168","document":"form4-02142019_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000168/form4-02142019_040201.xml","form_type":"4"}},{"id":3658637,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-14T16:05:14.000Z","date":"2019-01-14","kind":"gift","acquired":false,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":57913,"source":{"system":"sec-edgar","filing":"0001415889-19-000168","document":"form4-02142019_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000168/form4-02142019_040201.xml","form_type":"4"}},{"id":3674607,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T17:42:45.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in four equal quarterly installments from the option grant date."}],"balance_after":49000,"derivative":{"exercise_price":9.91,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001250853-19-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000125085319000041/primary_doc.xml","form_type":"4"}},{"id":3723922,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-20T16:48:48.000Z","date":"2018-12-19","kind":"exercise","acquired":false,"shares":8600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":59.055,"expiration_date":"2023-06-12","underlying":"Common Stock","underlying_shares":8600},"source":{"system":"sec-edgar","filing":"0001415889-18-001812","document":"form4-12202018_011232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918001812/form4-12202018_011232.xml","form_type":"4"}},{"id":3723921,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-20T16:48:48.000Z","date":"2018-12-19","kind":"exercise","acquired":true,"shares":8600,"price":59.055,"value":507873.0,"ownership":{"direct":true},"balance_after":63013,"source":{"system":"sec-edgar","filing":"0001415889-18-001812","document":"form4-12202018_011232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918001812/form4-12202018_011232.xml","form_type":"4"}},{"id":3751165,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-28T16:05:17.000Z","date":"2018-11-26","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully exercisable."}],"balance_after":8600,"derivative":{"exercise_price":59.055,"expiration_date":"2023-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-18-001688","document":"form4-11282018_041101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918001688/form4-11282018_041101.xml","form_type":"4"}},{"id":3751164,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-28T16:05:17.000Z","date":"2018-11-26","kind":"exercise","acquired":true,"shares":10000,"price":59.055,"value":590550.0,"ownership":{"direct":true},"balance_after":54413,"source":{"system":"sec-edgar","filing":"0001415889-18-001688","document":"form4-11282018_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918001688/form4-11282018_041101.xml","form_type":"4"}},{"id":3779062,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-10-31T18:56:02.000Z","date":"2018-10-29","kind":"exercise","acquired":false,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 44,000 shares, became exercisable in four equal quarterly installments following the date of grant, which was January 8, 2016."}],"balance_after":0,"derivative":{"exercise_price":3.45,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001250853-18-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000125085318000135/primary_doc.xml","form_type":"4"}},{"id":3779061,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-10-31T18:56:02.000Z","date":"2018-10-29","kind":"exercise","acquired":false,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, representing a right to purchase a total of 20,000 shares, became exercisable as to 5,000 shares beginning on August 29, 2014, which was the first anniversary of the date on which the option was granted, and the remaining shares vested in equal monthly installments over the following 36 months."}],"balance_after":0,"derivative":{"exercise_price":1.37,"expiration_date":"2023-08-28","underlying":"Common Stock","underlying_shares":833},"source":{"system":"sec-edgar","filing":"0001250853-18-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000125085318000135/primary_doc.xml","form_type":"4"}},{"id":3779060,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-31T18:56:02.000Z","date":"2018-10-29","kind":"exercise","acquired":true,"shares":44000,"price":3.45,"value":151800.0,"ownership":{"direct":true},"balance_after":169000,"source":{"system":"sec-edgar","filing":"0001250853-18-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000125085318000135/primary_doc.xml","form_type":"4"}},{"id":3779059,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-31T18:56:02.000Z","date":"2018-10-29","kind":"exercise","acquired":true,"shares":833,"price":1.37,"value":1141.21,"ownership":{"direct":true},"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001250853-18-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000125085318000135/primary_doc.xml","form_type":"4"}},{"id":3846632,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-13T16:05:17.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":12000,"price":92.324,"value":1107888.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold by the reporting person in multiple transactions at prices ranging from $92.310 to $92.325, inclusive. The reporting person undertakes to provide Celgene Corporation (the \"Company\"), any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":44413,"source":{"system":"sec-edgar","filing":"0001415889-18-001260","document":"form4-08132018_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918001260/form4-08132018_040801.xml","form_type":"4"}},{"id":3860989,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T18:12:40.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":4465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control."}],"balance_after":4465,"derivative":{"exercise_price":6.2,"expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":4465},"source":{"system":"sec-edgar","filing":"0001638599-18-000822","document":"doc4_5553.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859918000822/doc4_5553.xml","form_type":"4"}},{"id":3860988,"issuer":{"id":7220,"kind":"organization","name":"HYPERION DEFI, INC."},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001","published_at":"2018-07-26T18:12:40.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":4033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control."}],"balance_after":146770,"source":{"system":"sec-edgar","filing":"0001638599-18-000822","document":"doc4_5553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000163859918000822/doc4_5553.xml","form_type":"4"}},{"id":3882410,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-27T16:30:40.000Z","date":"2018-06-25","kind":"purchase","acquired":true,"shares":16500,"price":4.48,"value":73920.0,"ownership":{"direct":false,"nature":"By Ernest and Mildred Mario Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.46 to $4.52 per share, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp. (\"Tonix\"), any security holder of Tonix, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001615774-18-005782","document":"s111042_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000161577418005782/s111042_form4.xml","form_type":"4"}},{"id":3883244,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-26T19:48:35.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in four quarterly installments following the grant date."}],"balance_after":10000,"derivative":{"exercise_price":11,"expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001250853-18-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000125085318000092/primary_doc.xml","form_type":"4"}},{"id":3890904,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2018-06-18T18:10:38.000Z","date":"2018-06-11","kind":"grant","acquired":true,"shares":15931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the Option shall vest on the one year anniversary on the Vesting Commencement Date (which is June 11, 2018) or the date of the 2018 Annual Shareholder Meeting, whichever is earlier."}],"balance_after":15931,"derivative":{"exercise_price":2.04,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":15931},"source":{"system":"sec-edgar","filing":"0000899243-18-017046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318017046/doc4.xml","form_type":"4"}},{"id":3891663,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-18T16:00:35.000Z","date":"2018-06-17","kind":"exercise","acquired":false,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":334},"source":{"system":"sec-edgar","filing":"0001415889-18-000951","document":"form4-06182018_040619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000951/form4-06182018_040619.xml","form_type":"4"}},{"id":3891662,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-18T16:00:35.000Z","date":"2018-06-17","kind":"exercise","acquired":true,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."}],"balance_after":56413,"source":{"system":"sec-edgar","filing":"0001415889-18-000951","document":"form4-06182018_040619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000951/form4-06182018_040619.xml","form_type":"4"}},{"id":3893138,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-15T16:23:26.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"One-third of the restricted stock units granted to the reporting person June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"The remainder of the restricted stock units will vest on June 15, 2019. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the restricted stock units granted to the reporting person June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third of the restricted stock units granted to the reporting person June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":375,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001415889-18-000941","document":"form4-06152018_010610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000941/form4-06152018_010610.xml","form_type":"4"}},{"id":3893137,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-15T16:23:26.000Z","date":"2018-06-14","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The remainder of the restricted stock units will vest in two annual installments as follows: 300 shares on June 14, 2019 and 300 shares on June 14, 2020. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."}],"balance_after":600,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001415889-18-000941","document":"form4-06152018_010610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000941/form4-06152018_010610.xml","form_type":"4"}},{"id":3893136,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-15T16:23:26.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":13266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Option is immediately exercisable and will vest on the earlier of June 13, 2019 or the day preceding the date of the next stockholder meeting."}],"balance_after":13266,"derivative":{"exercise_price":77.38,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":13266},"source":{"system":"sec-edgar","filing":"0001415889-18-000941","document":"form4-06152018_010610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000941/form4-06152018_010610.xml","form_type":"4"}},{"id":3893135,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-15T16:23:26.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":1454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units will vest in three annual installments as follows: 484 shares on June 13, 2019; 485 shares on June 13, 2020; and 485 shares on June 13, 2021. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units will vest in three annual installments as follows: 484 shares on June 13, 2019; 485 shares on June 13, 2020; and 485 shares on June 13, 2021. Vested shares will be delivered to the reporting person promptly after the vesting date."}],"balance_after":1454,"derivative":{"underlying":"Common Stock","underlying_shares":1454},"source":{"system":"sec-edgar","filing":"0001415889-18-000941","document":"form4-06152018_010610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000941/form4-06152018_010610.xml","form_type":"4"}},{"id":3893134,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T16:23:26.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"One-third of the restricted stock units granted to the reporting person June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":56079,"source":{"system":"sec-edgar","filing":"0001415889-18-000941","document":"form4-06152018_010610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000941/form4-06152018_010610.xml","form_type":"4"}},{"id":3893133,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T16:23:26.000Z","date":"2018-06-14","kind":"exercise","acquired":true,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."}],"balance_after":55704,"source":{"system":"sec-edgar","filing":"0001415889-18-000941","document":"form4-06152018_010610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000941/form4-06152018_010610.xml","form_type":"4"}},{"id":3895622,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-06-13T17:16:14.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."}],"balance_after":20000,"derivative":{"exercise_price":4.25,"exercise_date":"2019-06-12","expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001615774-18-005234","document":"s110814_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000161577418005234/s110814_form4.xml","form_type":"4"}},{"id":3895625,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-13T17:05:31.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":3606,"price":2.04,"value":7356.24,"ownership":{"direct":true},"balance_after":475324,"source":{"system":"sec-edgar","filing":"0000899243-18-016391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318016391/doc4.xml","form_type":"4"}},{"id":3895624,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-13T17:05:31.000Z","date":"2018-06-11","kind":"grant","acquired":true,"shares":500,"price":2.04,"value":1020.0,"ownership":{"direct":true},"balance_after":471718,"source":{"system":"sec-edgar","filing":"0000899243-18-016391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318016391/doc4.xml","form_type":"4"}},{"id":3895623,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-13T17:05:31.000Z","date":"2018-06-11","kind":"grant","acquired":true,"shares":4980,"price":2.05,"value":10209.0,"ownership":{"direct":true},"balance_after":471218,"source":{"system":"sec-edgar","filing":"0000899243-18-016391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318016391/doc4.xml","form_type":"4"}},{"id":3898571,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T16:01:56.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":14803,"price":2.044,"value":30257.332,"ownership":{"direct":true},"balance_after":466238,"source":{"system":"sec-edgar","filing":"0000899243-18-015955","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318015955/doc4.xml","form_type":"4"}},{"id":3898570,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T16:01:56.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":4611,"price":2.0025,"value":9233.5275,"ownership":{"direct":true},"balance_after":451435,"source":{"system":"sec-edgar","filing":"0000899243-18-015955","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318015955/doc4.xml","form_type":"4"}},{"id":3901806,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-07T15:10:24.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":1200,"price":2.05,"value":2460.0,"ownership":{"direct":true},"balance_after":446824,"source":{"system":"sec-edgar","filing":"0000899243-18-015421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318015421/doc4.xml","form_type":"4"}},{"id":3908615,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-04T16:54:53.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":1300,"price":2.05,"value":2665.0,"ownership":{"direct":true},"balance_after":445624,"source":{"system":"sec-edgar","filing":"0000899243-18-014931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318014931/doc4.xml","form_type":"4"}},{"id":3908614,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-04T16:54:53.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":500,"price":2.05,"value":1025.0,"ownership":{"direct":true},"balance_after":444324,"source":{"system":"sec-edgar","filing":"0000899243-18-014931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318014931/doc4.xml","form_type":"4"}},{"id":3915673,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T18:18:28.000Z","date":"2018-05-29","kind":"grant","acquired":true,"shares":500,"price":2.01,"value":1005.0,"ownership":{"direct":true},"balance_after":443824,"source":{"system":"sec-edgar","filing":"0000899243-18-014306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318014306/doc4.xml","form_type":"4"}},{"id":3915672,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T18:18:28.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":5000,"price":2.05,"value":10250.0,"ownership":{"direct":true},"balance_after":443324,"source":{"system":"sec-edgar","filing":"0000899243-18-014306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318014306/doc4.xml","form_type":"4"}},{"id":3922218,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-22T16:57:07.000Z","date":"2018-05-21","kind":"grant","acquired":true,"shares":5000,"price":1.944,"value":9720.0,"ownership":{"direct":true},"balance_after":438324,"source":{"system":"sec-edgar","filing":"0000899243-18-013705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318013705/doc4.xml","form_type":"4"}},{"id":3922217,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-22T16:57:07.000Z","date":"2018-05-21","kind":"grant","acquired":true,"shares":25000,"price":1.95,"value":48750.0,"ownership":{"direct":true},"balance_after":433324,"source":{"system":"sec-edgar","filing":"0000899243-18-013705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318013705/doc4.xml","form_type":"4"}},{"id":3924190,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T18:26:32.000Z","date":"2018-05-18","kind":"grant","acquired":true,"shares":25000,"price":1.9,"value":47500.0,"ownership":{"direct":true},"balance_after":408324,"source":{"system":"sec-edgar","filing":"0000899243-18-013609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180469/000089924318013609/doc4.xml","form_type":"4"}},{"id":3924253,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T13:34:29.000Z","date":"2018-05-18","kind":"sale","acquired":false,"shares":15000,"price":4.8095,"value":72142.5,"ownership":{"direct":false,"nature":"By The Ernest and Mildred Mario Revocable Trust, Ernest and Mildred Mario, Trustees"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of sale prices received is $4.76 to $4.84. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":108167,"source":{"system":"sec-edgar","filing":"0001209191-18-031705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919118031705/doc4.xml","form_type":"4"}},{"id":3924252,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":90102,"kind":"person","name":"MARIO ERNEST","position":1,"cik":"0001180469","reported_name":"MARIO ERNEST","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T13:34:29.000Z","date":"2018-05-17","kind":"sale","acquired":false,"shares":30000,"price":4.7977,"value":143931.0,"ownership":{"direct":false,"nature":"By The Ernest and Mildred Mario Revocable Trust, Ernest and Mildred Mario, Trustees"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of sale prices received is $4.73 to $4.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":123167,"source":{"system":"sec-edgar","filing":"0001209191-18-031705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919118031705/doc4.xml","form_type":"4"}}],"next_cursor":"2018-05-21T13:34:29.000000Z,3924252"}